Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-02-28
2011-12-06
Hui, San-Ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S675000, C514S740000
Reexamination Certificate
active
08071630
ABSTRACT:
A method of treating an effect of a chemical agent, which agent is characterized by one or more chiral centres, by administering a dilution or an ultra-high dilution or potentised preparation of a stereoisomer of said chemical agent.
REFERENCES:
patent: 3432545 (1969-03-01), Howe
patent: 3534085 (1970-10-01), Narayanan et al.
patent: 3947592 (1976-03-01), Grosz
patent: 4346106 (1982-08-01), Sudilovsky
patent: 6239105 (2001-05-01), Brewitt
patent: 2008/0039523 (2008-02-01), Albert et al.
patent: 3829442 (1990-03-01), None
patent: A-1 277601 (1972-06-01), None
patent: 2141026 (1984-12-01), None
patent: 71050 (1998-01-01), None
patent: WO 91/00259 (1991-01-01), None
patent: WO 91 00259 (1991-10-01), None
patent: WO9814162 (1998-09-01), None
Howe R & Shanks RG, “Optical Isomers of Propranolol,” Nature, Jun. 1966, 210, 1336-1338.
Stedman's Medical Dictionary 27th ed., Lippincott Williams & Wilkins, 2000, p. 827.
Smith JG, “Organic Chemistry,”1st ed. McGraw Hill, Boston, 2006, p. 143.
Armstrong DW, Wang X, and Ercal N, “Enantiomeric Composition of Nicotine in Smokeless Tobacco, Medicinal Products, and Commerical Reagents,” Chirality, 1998, 10(7), 587-591.
Hauora M. Guidelines for Prescribing Psychotropic Drugs. Minystry of Health, 1996.
Farthing et al., J. Antimicrob. Chemother. “Effect of D-propanolol on Growth and Motility of Flagellate Protozoa,” 1987, 20(4), pp. 519-522. Chemical Abstracts, vol. 107, 1987, Abstract 232966a.
Chasin et al., J. Biol. Chem., “—and—Adrenergic Receptors as Mediators of Accumulation of Cyclic Adenosine 3′,5′—Monophosphate in Specific Areas of Guinea Pig Brain,” vol. 246, No. 9, issued May 10, 1971, pp. 3037-3041.
Grimes et al., Invest. Ophthalmol. “Possible Cyclic Adenosine Monophosphate Mediation in Isoproterenol-induced Suppression of Cell Division in Rat Lens Epithelium,” 1972, 11(4), pp. 231-235. Chemical Abstracts, vol. 77, 1972, Abstract 43303h.
Nilsson et al., Acta Endocrinol (Copenhagen), “Effects of Propranolol and Atenolol on Plasma and Urinary Cyclic Adenosine 3′,5′—Monophosphate in Hyperthyroid Patients,” 1980 94(1), pp. 38-45. Chemical Abstracts, vol. 93, 1980, Abstract 88913d.
Larsson P T et al: “Alpha and Beta-adrenergic influences . . . ” Firbrinolysis, Churchill Livingston, London, GB, vol. 13. No. 4-5, Jul. 1999, pp. 169-175.
Jonas and Tortella: “Neuroprotection from glutamate toxicity with ultra-low dose glutamate”, Neuroreport, Rapid Comms. GB vol. 12, NR-2, p. 335-339, Feb. 12, 2001.
Bonamin et al., Do Rio R G: “Very high dilutions of dexamethasone inhibit its pharmacological effects in vivo”, British Homoeopathic J., Oct. 2001, vol. 90, 198-203.
Hui San-Ming
Premier Law Group, PLLC
Wood Christopher
Zarek Paul
LandOfFree
Treatment of effect of chemicals with their ultradilute... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of effect of chemicals with their ultradilute..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of effect of chemicals with their ultradilute... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4269923